COBRE for the Center for Molecular Medicine: Scope - Single Cell Characterization of Leukemia Stem Cells to Improve Patient Outcome

Grants and Contracts Details


Patients with relapsed Acute Lymphoblastic Leukemia (ALL) have a poor prognosis because their therapeutic options are limited. Relapse is thought to arise from leukemia stem cells, which have the unique ability to self-renew to reform tumor from a single cell. These cells are rare in human disease and mouse models, making up
Effective start/end date7/1/144/30/18


  • National Institute of General Medical Sciences


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.